β-Nicotinamide mononucleotide, reduced form disodium

Overview

β-Nicotinamide mononucleotide, reduced form (NMNH) disodium is an orally active reduced version of β-Nicotinamide mononucleotide ( HY-F0004 ). β-Nicotinamide mononucleotide, reduced form disodium can significantly increase the levels of NAD + and NADH , inhibit glycolysis, the tricarboxylic acid cycle, and cell growth, with its effects being dependent on nicotinamide mononucleotide adenylyltransferase (NMNAT).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-W615108B
• CAS No.: 108347-85-9
• Molecular Formula: C11H15N2Na2O8P
• Molecular Weight: 380.20
• Purity: 99.55%
• Storage: -20°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Availability: In-stock

Source

Original product source